|
US5668255A
(en)
|
1984-06-07 |
1997-09-16 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
|
US5674703A
(en)
|
1992-12-02 |
1997-10-07 |
Woo; Savio L. C. |
Episomal vector systems and related methods
|
|
SK282843B6
(sk)
|
1993-07-13 |
2002-12-03 |
Rhone-Poulenc Rorer S. A. |
Defektný rekombinantný adenovírus a farmaceutický prostriedok s jeho obsahom
|
|
EP1012236A1
(en)
*
|
1997-08-15 |
2000-06-28 |
Rubicon Laboratory Inc. |
Retrovirus and viral vectors
|
|
US6399383B1
(en)
*
|
1997-10-28 |
2002-06-04 |
Maxygen, Inc. |
Human papilloma virus vectors
|
|
EP1064393B1
(en)
|
1998-03-20 |
2004-12-29 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
EP2386646B1
(en)
|
1998-10-01 |
2016-12-21 |
University Of Southern California |
Gene delivery system and methods of use
|
|
US6156514A
(en)
*
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
|
US6410013B1
(en)
|
1999-01-25 |
2002-06-25 |
Musc Foundation For Research Development |
Viral vectors for use in monitoring HIV drug resistance
|
|
WO2000072886A1
(en)
*
|
1999-05-26 |
2000-12-07 |
Dana-Farber Cancer Institute, Inc. |
Episomally replicating lentiviral vectors
|
|
AU2001257611A1
(en)
|
2000-04-28 |
2001-11-12 |
Avigen, Inc. |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
CA2408830A1
(en)
|
2000-05-12 |
2001-11-22 |
The Regents Of The University Of California |
Treatment of human papillomavirus (hpv)-infected cells
|
|
US20060057553A1
(en)
|
2000-05-30 |
2006-03-16 |
Estuardo Aguilar-Cordova |
Chimeric viral vectors for gene therapy
|
|
NO314588B1
(no)
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
|
|
US7122181B2
(en)
|
2000-12-19 |
2006-10-17 |
Research Development Foundation |
Lentiviral vector-mediated gene transfer and uses thereof
|
|
US20030119770A1
(en)
|
2001-08-02 |
2003-06-26 |
Zhennan Lai |
Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors
|
|
AU2002323270A1
(en)
|
2001-08-18 |
2003-03-03 |
Myriad Genetics, Inc |
Composition and method for treating hiv infection
|
|
US7737124B2
(en)
|
2001-09-13 |
2010-06-15 |
California Institute Of Technology |
Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
|
|
US20070203333A1
(en)
|
2001-11-30 |
2007-08-30 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
|
AU2003224725A1
(en)
|
2002-03-20 |
2003-10-08 |
Brigham And Women's Hospital, Inc. |
Hiv therapeutic
|
|
US20040142416A1
(en)
|
2002-04-30 |
2004-07-22 |
Laipis Philip J. |
Treatment for phenylketonuria
|
|
US20040161412A1
(en)
*
|
2002-08-22 |
2004-08-19 |
The Cleveland Clinic Foundation |
Cell-based VEGF delivery
|
|
US8034334B2
(en)
|
2002-09-06 |
2011-10-11 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
|
|
AU2003290586B2
(en)
|
2002-11-04 |
2009-07-02 |
University Of Massachusetts |
Allele-specific RNA interference
|
|
AU2003283174A1
(en)
|
2002-12-11 |
2004-06-30 |
Cytos Biotechnology Ag |
Method for protein production
|
|
WO2004091572A2
(en)
|
2003-04-09 |
2004-10-28 |
Biodelivery Sciences International, Inc. |
Cochleate compositions directed against expression of proteins
|
|
US20060246520A1
(en)
|
2003-05-23 |
2006-11-02 |
Institut National De La Sante Et De La Recherche Medicale |
Gamma delta t cell-mediated therapy
|
|
EP1644508A1
(en)
|
2003-07-11 |
2006-04-12 |
Cytos Biotechnology AG |
Gene expression system
|
|
US20050019927A1
(en)
|
2003-07-13 |
2005-01-27 |
Markus Hildinger |
DECREASING GENE EXPRESSION IN A MAMMALIAN SUBJECT IN VIVO VIA AAV-MEDIATED RNAi EXPRESSION CASSETTE TRANSFER
|
|
US20050138677A1
(en)
|
2003-09-16 |
2005-06-23 |
Pfister Herbert J. |
Transgenic animal model for the treatment of skin tumors
|
|
WO2005028634A2
(en)
|
2003-09-18 |
2005-03-31 |
Emory University |
Improved mva vaccines
|
|
WO2005033282A2
(en)
*
|
2003-10-01 |
2005-04-14 |
Pharmacia & Upjohn Company Llc |
Polyamide compositions and therapeutic methods for treatment of human papilloma virus
|
|
US20080039413A1
(en)
|
2003-10-21 |
2008-02-14 |
Morris David W |
Novel compositions and methods in cancer
|
|
WO2005081911A2
(en)
|
2004-02-25 |
2005-09-09 |
Dana-Farber Cancer Institute, Inc. |
METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION USING TRIM5α
|
|
US20060058255A1
(en)
|
2004-03-01 |
2006-03-16 |
Jianzhu Chen |
RNAi-based therapeutics for allergic rhinitis and asthma
|
|
TW201705980A
(zh)
*
|
2004-04-09 |
2017-02-16 |
艾伯維生物技術有限責任公司 |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
US20080227736A1
(en)
|
2004-06-03 |
2008-09-18 |
Regents Of The University Of California, |
Targeting Pseudotyped Retroviral Vectors
|
|
US20080131940A1
(en)
|
2004-06-25 |
2008-06-05 |
Robert Chiu |
Target Cell-Specific Short Interfering Rna and Methods of Use Thereof
|
|
EP1789447B1
(en)
|
2004-08-16 |
2012-04-25 |
Immune Disease Institute, Inc. |
Method of delivering rna interference and uses thereof
|
|
US7358361B2
(en)
|
2004-10-08 |
2008-04-15 |
The Board Of Trustees Of The University Of Illinois |
Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
|
|
EP1647595A1
(en)
|
2004-10-15 |
2006-04-19 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Nucleic acids against viruses, in particular HIV
|
|
EP1809753A1
(en)
*
|
2004-11-02 |
2007-07-25 |
Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. |
Adenoviral amplicon and producer cells for the production of replication-defective adenoviral vectors, methods of preparation and use thereof
|
|
US7790446B2
(en)
|
2005-02-11 |
2010-09-07 |
Kosagen Cell Factory Oü |
Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
|
|
MX2007010008A
(es)
|
2005-02-16 |
2008-01-18 |
Lentigen Corp |
Vectores lentivirales y su uso.
|
|
CA2609142C
(en)
|
2005-05-27 |
2016-02-09 |
Fondazione Centro San Raffaele Del Monte Tabor |
Therapeutic gene vectors comprising mirna target sequences
|
|
US20070032443A1
(en)
|
2005-08-02 |
2007-02-08 |
Jaeseob Kim |
Therapy for Alzheimer's disease
|
|
WO2007015122A1
(en)
|
2005-08-02 |
2007-02-08 |
Genexel, Inc. |
Therapy for alzheimer’s disease
|
|
WO2007056388A2
(en)
|
2005-11-07 |
2007-05-18 |
The General Hospital Corporation |
Compositions and methods for modulating poly (adp-ribose) polymerase activity
|
|
GB0526211D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Viral vectors
|
|
WO2007133674A2
(en)
|
2006-05-12 |
2007-11-22 |
Lentigen Corporation |
Lentiviral vector compositions, methods and applications
|
|
WO2007149476A2
(en)
|
2006-06-19 |
2007-12-27 |
Trustees Of Columbia University In The City Of New York |
Assays for non-apoptotic cell death and uses thereof
|
|
US20080003225A1
(en)
|
2006-06-29 |
2008-01-03 |
Henri Vie |
Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors
|
|
WO2008008719A2
(en)
|
2006-07-10 |
2008-01-17 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the myc gene
|
|
EP1878440A1
(en)
|
2006-07-13 |
2008-01-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds
|
|
KR20090034395A
(ko)
|
2006-07-26 |
2009-04-07 |
노파르티스 아게 |
운데카프레닐 피로포스페이트 합성효소의 억제제
|
|
US20080199961A1
(en)
|
2006-08-25 |
2008-08-21 |
Avi Biopharma, Inc. |
ANTISENSE COMPOSITION AND METHOD FOR INHIBITION OF miRNA BIOGENESIS
|
|
EP2097517B1
(en)
|
2006-10-16 |
2014-06-04 |
Genelux Corporation |
Recombinant Lister strain vaccinia virus encoding an anti-VEGF single chain antibody
|
|
EP2126137B1
(en)
|
2007-01-23 |
2017-06-07 |
Janssen Pharmaceutica NV |
Method for designing a drug regime for hiv-infected patients
|
|
CN101679466A
(zh)
|
2007-04-12 |
2010-03-24 |
伊利诺伊大学评议会 |
对包括fpps、ggpps和dpps在内的多靶点效力提高的二膦酸盐化合物及方法
|
|
US20080293142A1
(en)
|
2007-04-19 |
2008-11-27 |
The Board Of Regents For Oklahoma State University |
Multiple shRNA Expression Vectors and Methods of Construction
|
|
EP2008656A1
(en)
|
2007-06-28 |
2008-12-31 |
Bergen Teknologioverforing AS |
Compositions for the treatment of hyperphenylalaninemia
|
|
WO2009026328A2
(en)
|
2007-08-21 |
2009-02-26 |
Immune Disease Institute, Inc. |
Methods of delivery of agents to leukocytes and endothelial cells
|
|
EP2090659A1
(en)
|
2008-02-14 |
2009-08-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Infectious particle, process for its preparation and use thereof
|
|
US8288094B2
(en)
*
|
2008-04-09 |
2012-10-16 |
Institut Pasteur |
APOBEC3 mediated DNA editing
|
|
GB0810209D0
(en)
|
2008-06-04 |
2008-07-09 |
Cambridge Entpr Ltd |
Pluripotency associated epigenetic factor
|
|
US8629334B2
(en)
|
2008-07-16 |
2014-01-14 |
University Of Florida Research Foundation, Inc. |
Viral-based transient-expression vector system for trees
|
|
WO2010022195A2
(en)
|
2008-08-20 |
2010-02-25 |
Virxsys Corporation |
Non-integrating lenti/adeno-associated virus hybrid vector system
|
|
WO2010033722A2
(en)
|
2008-09-17 |
2010-03-25 |
Isogenis, Inc. |
Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
|
|
US20100183558A1
(en)
|
2008-10-17 |
2010-07-22 |
Zhennan Lai |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
WO2010051521A1
(en)
|
2008-10-31 |
2010-05-06 |
Lentigen Corporation |
Cell therapy product for the treatment of hiv infection
|
|
WO2010051502A2
(en)
*
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
Light targeting molecules and uses thereof
|
|
JP2012508591A
(ja)
*
|
2008-11-14 |
2012-04-12 |
ライフ テクノロジーズ コーポレーション |
細胞を操作するための組成物および方法
|
|
EP2191834A1
(en)
|
2008-11-26 |
2010-06-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Compositions and methods for treating retrovirus infections
|
|
US20120034197A1
(en)
|
2009-04-09 |
2012-02-09 |
Stemcyte Inc. |
Hiv-resistant stem cells and uses thereof
|
|
RU2539099C2
(ru)
|
2009-04-13 |
2015-01-10 |
Апцет Гмбх Унд Ко.Кг |
Сконструированные мезенхимальные стволовые клетки и способ их применения для лечения опухолей
|
|
WO2010127166A2
(en)
|
2009-04-30 |
2010-11-04 |
The Regents Of The University Of California |
Combination anti-hiv vectors, targeting vectors, and methods of use
|
|
ES2657737T3
(es)
|
2009-07-15 |
2018-03-06 |
Calimmune Inc. |
Vector dual para la inhibición del virus de la inmunodeficiencia humana
|
|
US20120027725A1
(en)
|
2009-11-30 |
2012-02-02 |
Galvin Jeffrey A |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer
|
|
CN101805750B
(zh)
|
2009-12-29 |
2011-11-30 |
浙江大学 |
法呢基焦磷酸合成酶rna干扰重组慢病毒载体构建及用途
|
|
WO2011103417A2
(en)
|
2010-02-18 |
2011-08-25 |
Emory University Of Technology Transfer |
Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response
|
|
WO2011119942A1
(en)
|
2010-03-25 |
2011-09-29 |
Vistagen Therapeutics, Inc. |
Induction of ips cells using transient episomal vectors
|
|
US20130090371A1
(en)
|
2010-04-20 |
2013-04-11 |
President And Fellows Of Harvard College |
Methods and compositions for inhibition of beta2-adrenergic receptor degradation
|
|
US8993532B2
(en)
|
2010-04-23 |
2015-03-31 |
Cold Spring Harbor Laboratory |
Structurally designed shRNAs
|
|
WO2011148194A1
(en)
|
2010-05-28 |
2011-12-01 |
Oxford Biomedica (Uk) Ltd |
Delivery of lentiviral vectors to the brain
|
|
JP5805089B2
(ja)
|
2010-08-10 |
2015-11-04 |
タカラバイオ株式会社 |
細胞集団の製造方法
|
|
US20130281493A1
(en)
|
2010-10-07 |
2013-10-24 |
The Trustees Of The University Of Columbia In The City Of New York |
Method for Treating Cancer Harboring a p53 Mutation
|
|
WO2012061075A2
(en)
|
2010-10-25 |
2012-05-10 |
The Regents Of The University Of California |
Hiv resistant and functional hematopoietic stem/progenitor cells and macrophages from induced pluripotent stem cells
|
|
US8865881B2
(en)
|
2011-02-22 |
2014-10-21 |
California Institute Of Technology |
Delivery of proteins using adeno-associated virus (AAV) vectors
|
|
EP3318635A1
(en)
|
2011-04-21 |
2018-05-09 |
University of Massachusetts |
Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
|
HK1202434A1
(en)
|
2011-11-22 |
2015-10-02 |
The Children's Hospital Of Philadelphia |
Virus vectors for highly efficient transgene delivery
|
|
US9745631B2
(en)
|
2011-12-20 |
2017-08-29 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
|
JP6188728B2
(ja)
|
2012-02-07 |
2017-08-30 |
グローバル・バイオ・セラピューティクス・インコーポレイテッドＧｌｏｂａｌ Ｂｉｏ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
核酸送達の区画化方法ならびにその組成物および使用
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
AU2013273481B2
(en)
|
2012-06-06 |
2018-04-05 |
Bionor Immuno As |
HIV vaccine
|
|
EP2875133B1
(en)
|
2012-07-17 |
2018-01-10 |
Université de Genève |
Nucleic acids for down-regulation of gene expression
|
|
WO2014052855A1
(en)
|
2012-09-27 |
2014-04-03 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
|
CN105051192B
(zh)
|
2012-11-13 |
2020-04-17 |
科迪艾克生物科学公司 |
治疗剂的递送
|
|
US9255250B2
(en)
|
2012-12-05 |
2016-02-09 |
Sangamo Bioscience, Inc. |
Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene
|
|
US9642921B2
(en)
|
2012-12-20 |
2017-05-09 |
Tocagen Inc. |
Cancer combination therapy and recombinant vectors
|
|
WO2014117050A2
(en)
|
2013-01-26 |
2014-07-31 |
Mirimus, Inc. |
Modified mirna as a scaffold for shrna
|
|
CN103184224A
(zh)
|
2013-04-03 |
2013-07-03 |
衡阳师范学院 |
一种抗艾滋病病毒感染的三联miRNA及构建方法
|
|
EP3461909A1
(en)
|
2013-05-21 |
2019-04-03 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Isoforms of gata6 and nkx2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy
|
|
EP3027755B1
(en)
|
2013-08-02 |
2019-10-09 |
The Regents of The University of California |
Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors
|
|
WO2015042308A2
(en)
|
2013-09-18 |
2015-03-26 |
City Of Hope |
Rna-based hiv inhibitors
|
|
JP6506749B2
(ja)
|
2013-10-22 |
2019-04-24 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
フェニルケトン尿症のためのｍＲＮＡ療法
|
|
CN106459995B
(zh)
|
2013-11-07 |
2020-02-21 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
EP2878674A1
(en)
|
2013-11-28 |
2015-06-03 |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) |
Stable episomes based on non-integrative lentiviral vectors
|
|
GB201322091D0
(en)
|
2013-12-13 |
2014-01-29 |
Cambridge Entpr Ltd |
Modified serpins for the treatment of bleeding disorders
|
|
CA2946312A1
(en)
|
2014-04-23 |
2015-10-29 |
Juno Therapeutics, Inc. |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
CN114395559A
(zh)
|
2014-04-25 |
2022-04-26 |
吉尼松公司 |
高胆红素血症的治疗
|
|
PL3134432T3
(pl)
|
2014-04-25 |
2020-10-19 |
Bluebird Bio, Inc. |
Promotor mnd chimeryczne receptory antygenowe
|
|
US20160060707A1
(en)
|
2014-08-29 |
2016-03-03 |
Immunomedics, Inc. |
Identification of Cancer Genes by In-Vivo Fusion of Human Cancer Cells and Animal Cells
|
|
HRP20211601T1
(hr)
|
2014-09-22 |
2022-01-21 |
Tanea Medical Ab |
Rekombinantni proteini bez fenilalanina (phe) za liječenje fenilketonurije
|
|
EP3204420B1
(en)
|
2014-10-10 |
2020-09-02 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Methods to eliminate cancer stem cells by targeting cd47
|
|
CN107405357B
(zh)
|
2014-10-14 |
2021-12-31 |
德克萨斯科技大学系统 |
多重shRNAs及其应用
|
|
WO2016069716A1
(en)
|
2014-10-30 |
2016-05-06 |
The Scripps Research Institute |
Compositions and methods comprising tyrosyl-trna synthetases and resveratrol compounds
|
|
GB201509202D0
(en)
|
2015-05-28 |
2015-07-15 |
Ge Healthcare Bio Sciences Ab |
Semi-static cell culture
|
|
WO2016200997A1
(en)
*
|
2015-06-10 |
2016-12-15 |
America Gene Technologies International, Inc. |
Non-integrating viral delivery system and methods of use thereof
|
|
EP3319631A4
(en)
|
2015-07-08 |
2019-01-09 |
American Gene Technologies International Inc. |
HIV PREMUNICATION AND IMMUNOTHERAPY
|
|
WO2017025061A1
(en)
|
2015-08-13 |
2017-02-16 |
Peking University |
Induced extended pluripotent stem cells, methods of making and using
|
|
CN105112370B
(zh)
|
2015-08-25 |
2019-02-05 |
杭州优善生物科技有限公司 |
一种体外刺激外周血γδT细胞高效增殖的方法及其应用
|
|
WO2017068077A1
(en)
|
2015-10-20 |
2017-04-27 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and products for genetic engineering
|
|
WO2017100551A1
(en)
|
2015-12-09 |
2017-06-15 |
Alexion Pharmaceuticals, Inc. |
HETEROLOGOUS UTR SEQUENCES FOR ENHANCED mRNA EXPRESSION
|
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
CN116064678A
(zh)
|
2016-01-15 |
2023-05-05 |
美国基因技术国际有限公司 |
用于活化γ-δT细胞的方法和组合物
|
|
WO2017139065A1
(en)
|
2016-02-08 |
2017-08-17 |
American Gene Technologies International Inc. |
Hiv vaccination and immunotherapy
|
|
WO2017156311A2
(en)
|
2016-03-09 |
2017-09-14 |
American Gene Technologies International Inc. |
Combination vectors and methods for treating cancer
|
|
US20190117799A1
(en)
|
2016-04-01 |
2019-04-25 |
The Brigham And Women's Hospital, Inc. |
Stimuli-responsive nanoparticles for biomedical applications
|
|
EP3468617A4
(en)
|
2016-06-08 |
2020-01-22 |
American Gene Technologies International Inc. |
SYSTEM FOR THE NON-INTEGRAL VIRAL ISSUE AND PROCEDURE RELATING TO IT
|
|
AU2017292582C1
(en)
|
2016-07-08 |
2021-11-11 |
American Gene Technologies International Inc. |
HIV pre-immunization and immunotherapy
|
|
EP3487507A4
(en)
|
2016-07-21 |
2020-04-08 |
American Gene Technologies International, Inc. |
VIRAL VECTORS FOR THE TREATMENT OF PARKINSON'S DISEASE
|
|
KR102738752B1
(ko)
|
2016-12-30 |
2024-12-06 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
페닐케톤뇨증을 치료하기 위한 유전자 치료
|
|
JP7260170B2
(ja)
|
2017-01-09 |
2023-04-18 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
事前の免疫化ステップのないｈｉｖ免疫療法
|
|
AU2018219292B2
(en)
|
2017-02-08 |
2024-09-26 |
Dana-Farber Cancer Institute, Inc. |
Tunable endogenous protein degradation with heterobifunctional compounds
|
|
US11820999B2
(en)
|
2017-04-03 |
2023-11-21 |
American Gene Technologies International Inc. |
Compositions and methods for treating phenylketonuria
|
|
JP2020524996A
(ja)
|
2017-06-16 |
2020-08-27 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
ヒトガンマデルタｔ細胞を介する腫瘍細胞傷害性の活性化のための方法および組成物
|
|
CA3077355A1
(en)
|
2017-10-02 |
2019-04-11 |
American Gene Technologies International Inc. |
Vectors with promoter and enhancer combinations for treating phenylketonuria
|
|
US11352646B2
(en)
|
2018-11-05 |
2022-06-07 |
American Gene Technologies International Inc. |
Vector system for expressing regulatory RNA
|
|
BR112021024124A2
(pt)
|
2019-05-31 |
2022-01-11 |
American Gene Tech Int Inc |
Expressão otimizada de fenilalanina hidroxilase
|